Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Methoxy-2-(trifluoromethyl)benzylamine (4MTA) is a benzoic acid derivative that has been shown to inhibit the activity of enzymes involved in neurotransmitter synthesis. 4MTA inhibits the activity of acetylcholinesterase and butyrylcholinesterase, which are enzymes involved in the synthesis of acetylcholine. This inhibition leads to an accumulation of acetylcholine at synapses, causing an increase in the release of this neurotransmitter. The increased release of acetylcholine leads to an increase in its binding to receptors on postsynaptic cells, causing a reduction in neuronal excitability. 4MTA is also used as a positron emission tomography (PET) tracer due to its ability to bind with high affinity to cholinergic neurons by desmethylation in vivo.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2,2-Difluoroethyl ethyl carbonate is an electrolyte that belongs to the group of pyridinium salts. It is a colorless liquid with a layered structure and a melting point of -28°C. 2,2-Difluoroethyl ethyl carbonate has been used in Japan for the treatment of sectional bronchitis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Ethyl 3-tert-butyl-1H-pyrazole-5-carboxylate (ETBP) is an orally active, water soluble prodrug of piperidine. ETBP has been shown to be safe and effective in monkeys, with low toxicity. ETBP interacts with CYP3A4 and can be metabolized by CYP2D6 to form a pharmacokinetic profile that is similar to the parent drug. The physicochemical properties of ETBP make it difficult for the drug to cross the blood brain barrier, which may limit its use as a psychotropic agent. Benzimidazole derivatives are structurally modified ETBP analogues that have been shown to have better bioavailability and reduced neurotoxicity.</p>

<p>4-(3-Bromophenyl)pyrazole is a chemical compound that belongs to the class of organic compounds known as pyrazoles. It is a white crystalline solid that reacts with water to produce hydrogen bromide. The reactivity of 4-(3-bromophenyl)pyrazole has been studied using thermogravimetric analysis and operational techniques, including magnetic resonance spectroscopy and calorimetry. The synthesize of this compound has been shown to be possible by reacting 3-bromobenzene with benzoyl chloride followed by reaction with potassium hydroxide in ethanol. The reactivity of 4-(3-bromophenyl)pyrazole has also been studied using magnetic resonance spectroscopy, which showed that it is a resonance molecule, meaning it has an electronically excited state.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Pregabalin Impurity 13 is a stereoselective, synthetic compound that has been shown to be an inhibitor of gamma-aminobutyric acid (GABA) receptors. It can be synthesized by reacting 4-isobutyl-2,6-piperidinedione with hydrochloric acid and xylene. Pregabalin Impurity 13 binds to the amino acid sequence of GABA receptors in such a way as to prevent them from opening. This prevents the binding of GABA molecules to the receptor and reduces the duration of inhibition of these receptors. Pregabalin Impurity 13 has been shown to have antimicrobial activity against faecalis, which is found in human intestines and can cause infection. The environmental pollution caused by this impurity is due to its xylene content.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>